{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:26:00Z","timestamp":1790886360487,"version":"4.1.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1097\/pas.0b013e31824a72c6","type":"journal-article","created":{"date-parts":[[2012,3,28]],"date-time":"2012-03-28T05:11:20Z","timestamp":1332911480000},"page":"799-807","source":"Crossref","is-referenced-by-count":161,"title":["Mesonephric Adenocarcinomas of the Uterine Cervix and Corpus"],"prefix":"10.1097","volume":"36","author":[{"given":"Sarah L.","family":"Kenny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary A.","family":"McBride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackie","family":"Jamison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Glenn","family":"McCluggage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210131","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1365-2559.2004.01787.x","article-title":"WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing serous and ovarian endometrioid carcinoma.","volume":"44","author":"Al-Hussaini","year":"2004","journal-title":"Histopathology"},{"key":"R2-2-20210131","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/00000478-200405000-00006","article-title":"Malignant mesonephric tumors of the female genital tract. A clinicopathologic study of 9 cases.","volume":"28","author":"Bague","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R3-2-20210131","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/PGP.0b013e31821ac6c3","article-title":"Immunoexpression of PAX 8 in endometrial cancer: relation to high-grade carcinoma and p53.","volume":"30","author":"Brunner","year":"2011","journal-title":"Int J Gynecol Pathol"},{"key":"R4-2-20210131","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/01.pgp.0000235065.31301.3e","article-title":"Immunohistochemical overexpression of p16 and p53 in uterine serous carcinoma and ovarian high-grade serous carcinoma.","volume":"26","author":"Chiesa-Vottero","year":"2007","journal-title":"Int J Gynecol Pathol"},{"key":"R5-2-20210131","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1097\/00000478-199510000-00006","article-title":"Malignant mesonephric neoplasms of the uterine cervix. A report of eight cases, including four with a malignant spindle cell component.","volume":"19","author":"Clement","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"R6-2-20210131","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.prp.2011.08.009","article-title":"Thyroid transcription factor-1 expression in colorectal adenocarcinomas.","volume":"207","author":"Dettmer","year":"2011","journal-title":"Pathol Res Pract"},{"key":"R7-2-20210131","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/(SICI)1098-2264(199908)25:4<316::AID-GCC2>3.0.CO;2-0","article-title":"HMGIC expression in human adult and fetal tissues and in uterine leiomyomata.","volume":"25","author":"Gattas","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"R8-2-20210131","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1309\/K84K-005F-TCB8-FV4B","article-title":"WT-1 immunoreactivity in uterine papillary serous carcinoma is different from ovarian serous carcinomas.","volume":"117","author":"Goldstein","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"R9-2-20210131","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/01.pgp.0000092130.10100.88","article-title":"Wilms tumor gene immunoreactivity in primary serous carcinomas of the fallopian tube, ovary, endometrium and peritoneum.","volume":"22","author":"Hashi","year":"2003","journal-title":"Int J Gynecol Pathol"},{"key":"R10-2-20210131","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/modpathol.3800316","article-title":"Prevalence of human papilloma virus DNA in various histological subtypes of cervical adenocarcinoma: a population-based study.","volume":"18","author":"Hee","year":"2005","journal-title":"Mod Pathol"},{"key":"R12-2-20210131","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1365-2559.2010.03632.x","article-title":"P16 immunoreactivity in unusual types of cervical adenocarcinoma does not reflect human papillomavirus infection.","volume":"57","author":"Houghton","year":"2010","journal-title":"Histopathology"},{"key":"R13-2-20210131","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/PAS.0b013e3181788546","article-title":"A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary.","volume":"33","author":"Kobel","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R14-2-20210131","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/modpathol.2008.4","article-title":"Thyroid transcription factor-1 expression in ovarian epithelial neoplasms.","volume":"21","author":"Kubba","year":"2008","journal-title":"Mod Pathol"},{"key":"R15-2-20210131","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/PAS.0b013e3181da7687","article-title":"PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma.","volume":"34","author":"Laury","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R16-2-20210131","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/PAS.0b013e318216c112","article-title":"A Comprehensive Analysis of PAX8 expression in human epithelial tumors.","volume":"35","author":"Laury","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R17-2-20210131","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/modpathol.2010.49","article-title":"HMGA2: a biomarker significantly overexpressed in high-grade ovarian serous carcinoma.","volume":"23","author":"Mahajan","year":"2010","journal-title":"Mod Pathol"},{"key":"R18-2-20210131","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1136\/ijgc-00009577-200605000-00079","article-title":"Second case of uterine mesonephric adenocarcinoma.","volume":"16","author":"Marquette","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"R19-2-20210131","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00004347-200404000-00002","article-title":"WT1 is of value in ascertaining the site of origin of serous carcinomas within the female genital tract.","volume":"23","author":"McCluggage","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"R20-2-20210131","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/PAS.0b013e3181e32a11","article-title":"HMGA2 is a sensitive but not specific immunohistochemical marker of vulvovaginal aggressive angiomyxoma.","volume":"34","author":"McCluggage","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R22-2-20210131","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/PAS.0b013e3181d1d457","article-title":"An immunohistochemical study of cervical neuroendocrine carcinomas: neoplasms which are commonly TTF1 positive and which may express CK20 and p63.","volume":"34","author":"McCluggage","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R23-2-20210131","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1046\/j.1365-2559.2003.01684.x","article-title":"CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.","volume":"43","author":"McCluggage","year":"2003","journal-title":"Histopathology"},{"key":"R24-2-20210131","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1097\/PAS.0b013e31816d71ad","article-title":"Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas.","volume":"32","author":"Nonaka","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R27-2-20210131","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1097\/00000478-200112000-00011","article-title":"Mesonephric adenocarcinoma of the uterine corpus: CD10 expression as evidence of mesonephric differentiation.","volume":"25","author":"Ordi","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R28-2-20210131","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/00000478-200302000-00005","article-title":"CD10 expression in epithelial tissues and tumors of the gynecologic tract.","volume":"27","author":"Ordi","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R29-2-20210131","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1097\/PAS.0b013e31822d787c","article-title":"PAX2 and PAX8 expression in primary and metastatic Mullerian epithelial tumors: a comprehensive comparison.","volume":"35","author":"Ozcan","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R30-2-20210131","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/PAS.0b013e31821534b9","article-title":"Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus.","volume":"35","author":"Park","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R31-2-20210131","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0002-9440(10)64619-6","article-title":"Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma.","volume":"157","author":"Pirog","year":"2000","journal-title":"Am J Pathol"},{"key":"R32-2-20210131","first-page":"775","article-title":"HMGI-C expression patterns in human tissues. Implications for the genesis of frequent mesenchymal tumors.","volume":"149","author":"Rogalla","year":"1996","journal-title":"Am J Pathol"},{"key":"R33-2-20210131","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/00004347-200004000-00010","article-title":"Immunohistochemical detection of the Wilms tumor gene (WT1) in epithelial ovarian tumors.","volume":"19","author":"Shimizu","year":"2000","journal-title":"Int J Gynecol Pathol"},{"key":"R34-2-20210131","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1097\/PAS.0b013e3181131e21","article-title":"Thyroid transcription factor-1 expression in endometrial and endocervical adenocarcinomas.","volume":"31","author":"Siami","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R35-2-20210131","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00000478-200103000-00013","article-title":"Mesonephric adenocarcinomas of the uterine cervix: a study of 11 cases with immunohistochemical findings.","volume":"25","author":"Silver","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R36-2-20210131","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1097\/PAS.0b013e318227e2ee","article-title":"PAX8 and PAX2 immunostaining facilitates the diagnosis of primary epithelial neoplasms of the male genital tract.","volume":"35","author":"Tong","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R37-2-20210131","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/S0002-9440(10)63605-X","article-title":"Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma.","volume":"163","author":"Tsuchiya","year":"2003","journal-title":"Am J Pathol"},{"key":"R38-2-20210131","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"R39-2-20210131","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/PAS.0b013e3181be5d72","article-title":"HMGA2: a potential biomarker complement to P53 for detection of early-stage high-grade papillary serous carcinoma in fallopian tubes.","volume":"34","author":"Wei","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R40-2-20210131","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.humpath.2006.12.018","article-title":"Immunohistochemical detection of hepatocyte nuclear factor 1beta in ovarian and endometrial clear-cell adenocarcinomas and nonneoplastic endometrium.","volume":"38","author":"Yamamoto","year":"2007","journal-title":"Hum Pathol"},{"key":"R42-2-20210131","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1046\/j.1365-2559.2002.01462.x","article-title":"Endocervical adenocarcinoma and its variants: their morphology and differential diagnosis.","volume":"41","author":"Young","year":"2002","journal-title":"Histopathology"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000478-201206000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:34:57Z","timestamp":1786048497000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000478-201206000-00002"}},"subtitle":["HPV-negative Neoplasms That Are Commonly PAX8, CA125, and HMGA2 Positive and That May Be Immunoreactive With TTF1 and Hepatocyte Nuclear Factor 1-\u03b2"],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0b013e31824a72c6","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}